Genomic Landscape and Endocrine-Resistant Subgroup in Estrogen Receptor-Positive, Progesterone Receptor-Negative, and HER2-Negative Breast Cancer.

Theranostics · 2018 · PMC6299689 · PMID 30613307

Europe PMC DOI

hedged sentence

0.0600

closest p · 1.2× alpha

0.0600

boldest claim

The sentences

showed a trendP=0.060so close (0.05 < p ≤ 0.1)

Univariate and multivariate analyses showed that ZNF703 amplification was an independent prognostic factor ( Table S10 ), while RPS6KB1 amplification showed a trend towards predicting worse BCSS independently (P=0.060).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.